Fred Strohmeier
Plus aucun poste en cours
Profil
Mr. Fred Strohmeier is Senior Vice President at Agilent Technologies, Inc.
Mr. Strohmeier was previously employed as President & Managing Director by Agilent Technologies Deutschland GmbH.
He received his undergraduate degree from the University of Karlsruhe.
Anciens postes connus de Fred Strohmeier
| Sociétés | Poste | Fin |
|---|---|---|
Agilent Technologies Deutschland GmbH
 Agilent Technologies Deutschland GmbH Medical SpecialtiesHealth Technology Part of Agilent Technologies, Inc., Agilent Technologies Deutschland GmbH is a German company that delivers complete scientific solutions to help customers achieve superior outcomes in their labs, clinics, business, and the world they seek to improve. The company is based in Waldbronn, Germany. Agilent offers an in vitro diagnostic software suite that simplifies workflows and minimizes staff training requirements. The agilent resolution ctdx portfolio of assays provides clinicians and researchers with genomic information for cancer subjects. The ctdx platform is designed to detect genomic alterations in cell-free DNA (cfdna) with a simple blood draw. Agilent's online capabilities make it easier to manage accounts and streamline tasks in one central, secure location. The company was founded in 2016, and the CEO is Andreas Kistner. | President | - |
| AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Formation de Fred Strohmeier
| University of Karlsruhe | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AGILENT TECHNOLOGIES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Agilent Technologies Deutschland GmbH
Agilent Technologies Deutschland GmbH Medical SpecialtiesHealth Technology Part of Agilent Technologies, Inc., Agilent Technologies Deutschland GmbH is a German company that delivers complete scientific solutions to help customers achieve superior outcomes in their labs, clinics, business, and the world they seek to improve. The company is based in Waldbronn, Germany. Agilent offers an in vitro diagnostic software suite that simplifies workflows and minimizes staff training requirements. The agilent resolution ctdx portfolio of assays provides clinicians and researchers with genomic information for cancer subjects. The ctdx platform is designed to detect genomic alterations in cell-free DNA (cfdna) with a simple blood draw. Agilent's online capabilities make it easier to manage accounts and streamline tasks in one central, secure location. The company was founded in 2016, and the CEO is Andreas Kistner. | Health Technology |